Genematrix

Genematrix Forward P/E

The Forward P/E Ratio of Genematrix (109820.KQ) as of Oct 16, 2026 is -22.75. In the previous year, Forward P/E Ratio was -11.13 — a change of 104.32% (lower).

Forward P/E

-22.75

YoY

104.32%

Last updated:

Forward P/E Ratio of Genematrix is 2025 -22.75 . Forward P/E Ratio of Genematrix was 2024 -11.13 . It decreases by 104.32% lower compared to the previous year.

The Genematrix Forward P/E history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Forward P/E
Date
Forward P/E
Jan 1, 2018
-13.43 KRW
Jan 1, 2019
-30.53 KRW
Jan 1, 2020
5.20 KRW
Jan 1, 2021
-42.25 KRW
Jan 1, 2022
-5.14 KRW
Jan 1, 2023
-46.62 KRW
Jan 1, 2024
-11.13 KRW
Jan 1, 2025
-22.75 KRW
The Genematrix Forward P/E history
YEARForward P/EYoY
-22.75+104.32%
-11.13-76.12%
-46.62+806.36%
-5.14-87.82%
-42.25-913.01%
5.20-117.02%
-30.53+127.34%
-13.43-52.69%
-28.39+156.98%
-11.05-46.52%
-20.66-44.42%
-37.16—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Genematrix Stock analysis

What does Genematrix do? Genematrix Inc is a health care company listed on the Korean market in November 2009, headquartered in Seongnam with 61 employees. It operates in pharmaceutical development and diagnostic medicine. The firm develops restriction fragment mass polymorphism genotyping technology for diagnosing hepatitis B, hepatitis C, and human papillomavirus. Additionally, it manufactures and sells liver-function examination reagents and handles the import and sale of medical equipment and reagents. Genematrix is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Genematrix stock

Forward P/E Ratio of Genematrix is -22.75 in 2025.

Forward P/E Ratio of Genematrix changed from -11.13 to -22.75, representing a 104.32% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Forward P/E Ratio Genematrix since 2006 – with annual values, charts, and detailed analysis.

The Forward P/E uses estimated future earnings to value a stock. A lower forward P/E relative to the trailing P/E suggests analysts expect earnings growth.

To evaluate Forward P/E Ratio's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Forward P/E Ratio.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Forward P/E Ratio's Genematrix with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Genematrix

All Key Metrics — Genematrix